Eli Lilly (NYSE: LLY) sells a broad range of pharmaceuticals treating various diseases, but one portfolio in particular has ...

Company acquiring former Butler prison seeks Wayne County IDA assistance for redevelopment ...

Spanning 176 weeks of treatment, the Phase III trial evaluated the efficacy and safety of tirzepatide in adults without type ...

Omega Therapeutics is halting work on its only clinical-stage candidate as part of a strategic refocus centered on three ...

Inovio Pharmaceuticals (NASDAQ: INO) Q3 2024 Earnings Call Nov 14, 2024, 4:30 p.m. ET ...

For more than five years, construction hoarding and steel fences have kept the public away from Parliament’s Centre Block as ...

Three buildings on Commercial Street have been a pain to village officials for long enough. Now that they’re slated for ...

Daré Bioscience ( (DARE) ) has released its Q3 earnings. Here is a breakdown of the information Daré Bioscience presented to its investors.

The Full Super Moon occults the Pleiades, the ice giant Uranus reaches opposition, and the Leonid meteor shower peaks in the ...

The Italian Parliament has agreed to support the country's efforts with the UK-led Global Combat Air Program (GCAP). Japan is ...

Good morning, and welcome to Local Bounti's Third Quarter 2024 Earnings Conference Call. All participants will be in a listen-only mode. After today's presentation, there will an opportunity to ask ...

A $3 billion mixed-use project is advancing in Frisco, with plans to include a $400 million Las Vegas-style hotel among its ...